Studies have begun to identify host specific pathways and factors that are involved in CS induced infection pathogenesis, such as CCR2, IL-17 and MAP3K19, and thus represent exciting immediate potential therapeutic targets for treatment. The gene discussed is IL17A; the disease is Cowden syndrome 1.